| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |